Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

440 public trials 66 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)

NCT00897130

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: University of Bologna Bologna, Italy

Chair of Haematology, Bone Marrow Transplant Unit Brescia, Italy

Cremona Cremona, Italy

University of Genova Genova, Italy

View Trial Details

Completed

Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia

NCT00005937

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

NCT00433745

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load

NCT00452660

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Wolfsom Medical Center Holon, Israel

View Trial Details

Completed

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

NCT00640796

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +19 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Clofarabine in High Risk Myelodysplastic Syndrome (MDS)

NCT01063257

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Hôpital Avicenne Bobigny, France

Institut Paoli-Calmettes Marseille, France

Hôpital Saint-Louis Paris, France

Hopital Cochin Service d'Hématologie Paris, France

View Trial Details

Completed

Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome

NCT02060409

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

NCT00774046

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

PRO#0118: Decitabine Plus Mini Flu-Bu

NCT01455506

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Hackensack University Medical Center - John Theurer Cancer Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

NCT01068301

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Myelodysplastic Syndrome

Myelodysplastic Syndrome trial results

Related conditions